1)  Imatinib mesylate
格列卫
1.
Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negavitation of Philadelphia chromosome;
格列卫治疗慢性粒细胞白血病Ph染色体转阴后进行自体外周血干细胞移植的结果
2.
OBJECTIVE To study the effectiveness of arsenic trioxide(As_2O_3) combined with Imatinib mesylate in refractory chronic myelocytic leukemia,because Imatinib and As_2O_3 have different effective target and have no across tolerance.
目的通过As2O3联合格列卫对Bac/Abl的作用靶点及二者药物作用无交叉耐药性的机制,达到使两种药发挥协同作用,更有效地治疗难治性慢性粒细胞白血病的目的。
2)  Imatinib mesylate
甲磺酸马替尼
3)  imatinib mesylate
甲磺酸伊马替尼
1.
Effects of Imatinib Mesylate in Patients with Chronic Myeloid Leukemia;
甲磺酸伊马替尼治疗慢性粒细胞白血病的循征评价
2.
Hydropericardium due to imatinib mesylate;
甲磺酸伊马替尼胶囊引起心包积液
3.
Adverse effects and precautions of imatinib mesylate;
甲磺酸伊马替尼的不良反应及预防处理
4)  Imatinib mesylate/therapeutic use
甲磺酸伊马替尼/治疗应用
5)  Imatinib
伊马替尼
1.
Efficacy and safety of Imatinib for Ph positive patients of chronic myeloid leukemia;
伊马替尼治疗Ph染色体阳性慢性粒细胞白血病的临床观察
2.
Establishment of an Imatinib Resistance Cell Line K562R and Its Resistant Principia;
体外诱导K562细胞伊马替尼耐药及其机理的初步探讨
3.
Imatinib mesylate combined with hematopiotic stem cell transplantation for chronic myloid leukemia;
伊马替尼联合造血干细胞移植治疗慢性粒细胞白血病
6)  imatinib
格列卫
1.
Evidence-Based Treatment of a Patient with Chronic-Phase Chronic Myeloid Leukemia by Imatinib;
格列卫在1例慢性粒细胞白血病慢性期患者中的循证应用
2.
Objective To study the treatment and its possible mechanism of imatinib-induced severe fluid retention in chromic myeloid leukemia(CML).
目的探讨应用伊马替尼(格列卫)治疗慢性粒细胞白血病发生严重水潴留的处理及其可能的发生机制。
参考词条
补充资料：列卫
1.四周的防卫。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。